99 related articles for article (PubMed ID: 1501222)
1. Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidines.
Feng Z; Gollamudi R; Dillingham EO; Bond SE; Lyman BA; Purcell WP; Hill RJ; Korfmacher WA
J Med Chem; 1992 Aug; 35(16):2952-8. PubMed ID: 1501222
[TBL] [Abstract][Full Text] [Related]
2. Enantioselective antiplatelet actions of nipecotamides.
Gollamudi R; Feng Z; Dillingham EO; Bond SE; Han G; Salgia S
Thromb Res; 1993 Feb; 69(4):361-7. PubMed ID: 8470057
[TBL] [Abstract][Full Text] [Related]
3. New carbamoylpiperidines as human platelet aggregation inhibitors.
Guo Z; Zheng X; Thompson W; Dugdale M; Gollamudi R
Bioorg Med Chem; 2000 May; 8(5):1041-58. PubMed ID: 10882016
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.
Herron D; Dillingham EO; Lyman BA; Zheng X; Bond SE; Salgia SR; Gollamudi R
Prostaglandins Leukot Essent Fatty Acids; 1995 May; 52(5):309-18. PubMed ID: 7630919
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitors.
Zheng X; Salgia SR; Thompson WB; Dillingham EO; Bond SE; Feng Z; Prasad KR; Gollamudi R
J Med Chem; 1995 Jan; 38(1):180-8. PubMed ID: 7837229
[TBL] [Abstract][Full Text] [Related]
6. Investigation of platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids.
de Candia M; Summo L; Carrieri A; Altomare C; Nardecchia A; Cellamare S; Carotti A
Bioorg Med Chem; 2003 Apr; 11(7):1439-50. PubMed ID: 12628670
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouse.
Han G; Bannerman D; Handa RK; Dillingham EO; Lawrence WH; Gollamudi R
Gen Pharmacol; 1997 Apr; 28(4):617-21. PubMed ID: 9147034
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.
Hasegawa M; Sugidachi A; Ogawa T; Isobe T; Jakubowski JA; Asai F
Thromb Haemost; 2005 Sep; 94(3):593-8. PubMed ID: 16268477
[TBL] [Abstract][Full Text] [Related]
9. Chiral resolution of alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene, a novel antiplatelet compound.
Gollamudi R; Feng ZX
Chirality; 1991; 3(6):480-3. PubMed ID: 1812959
[TBL] [Abstract][Full Text] [Related]
10. Chiral resolution and absolute configuration of the enantiomers of 5-acetyl-2-methyl-4-methylsulfinyl-6-phenyl-3(2H)-pyridazinone and evaluation of their platelet aggregation inhibitory activity.
Azzolina O; Dal Piaz V; Collina S; Giovannoni MP; Tadini C
Chirality; 1997; 9(7):681-5. PubMed ID: 9366028
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of H2-receptor antagonists on platelet function in vitro.
Nakamura K; Kariyazono H; Shinkawa T; Yamaguchi T; Yamashita T; Ayukawa O; Moriyama Y; Yotsumoto G; Toyohira H; Taira A; Yamada K
Hum Exp Toxicol; 1999 Aug; 18(8):487-92. PubMed ID: 10462360
[TBL] [Abstract][Full Text] [Related]
12. Stereochemistry and biological activities of constituents from Cynanchum taiwanianum.
Lin CN; Huang PL; Wang JJ; Day SH; Lin HC; Wang JP; Ko YL; Teng CM
Biochim Biophys Acta; 1998 Mar; 1380(1):115-22. PubMed ID: 9545557
[TBL] [Abstract][Full Text] [Related]
13. Adenosine receptor agonists: synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA.
Camaioni E; Di Francesco E; Vittori S; Volpini R; Cristalli G
Bioorg Med Chem; 1997 Dec; 5(12):2267-75. PubMed ID: 9459024
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet activity of nipecotamides in experimental thrombosis in mice.
Lawrence WH; Howell RD; Gollamudi R
J Pharm Sci; 1994 Feb; 83(2):222-5. PubMed ID: 8169794
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets.
Lim H; Kubota K; Kobayashi A; Seki T; Ariga T
Biosci Biotechnol Biochem; 1999 Feb; 63(2):298-301. PubMed ID: 10192909
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Weber AA; Reimann S; Schrör K
Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide.
Lyman BA; Bond SE; Dillingham EO; Lawrence WH; Gollamudi R
Res Commun Chem Pathol Pharmacol; 1992 Dec; 78(3):279-88. PubMed ID: 1475529
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of agonist-induced rise in platelet Ca2+ by antithrombotic nipecotamides.
Gollamudi R; Dillingham EO; Bond SE
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):375-83. PubMed ID: 8075309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
